An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects

NCT02793154 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Early termination due to insufficient enrollment.

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Exenatide
DRUG: Albiglutide

Sponsor

GlaxoSmithKline

Collaborators

[object Object]